Lukas M. Braun

1.1k total citations
11 papers, 172 citations indexed

About

Lukas M. Braun is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Lukas M. Braun has authored 11 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in Lukas M. Braun's work include Immune Cell Function and Interaction (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lukas M. Braun is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lukas M. Braun collaborates with scholars based in Germany, Switzerland and China. Lukas M. Braun's co-authors include Robert Zeiser, Uwe A. Wittel, Bernd Kammerer, Simon Lagies, Stefan Fichtner‐Feigl, R. Klar, Saskia Hussung, Ralph Fritsch, Geoffroy Andrieux and Franziska Maria Uhl and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Analytical and Bioanalytical Chemistry.

In The Last Decade

Lukas M. Braun

11 papers receiving 172 citations

Peers

Lukas M. Braun

HEMAT

MB

ONCOL

IMMUN

GENET

Vassilios Aslanis United States

Sung-Soo Yoon South Korea

Metis Hasipek United States

Juan Manuel Alonso‐Domínguez Spain

Nobuyoshi Hanaoka Japan

Federica Portale Italy

Toshie Ogasawara Japan

Christian Reimann Germany

Sukhraj Pal Singh Dhami Ireland

Kota Yoshifuji Japan

Vassilios Aslanis United States

Lukas M. Braun

61 ×0.9

HEMAT

67 ×1.1

MB

72 ×1.4

ONCOL

42 ×1.0

IMMUN

34 ×1.2

GENET

Citations per year, relative to Lukas M. Braun Lukas M. Braun (= 1×) peers Vassilios Aslanis

Countries citing papers authored by Lukas M. Braun

Since Specialization

Citations

This map shows the geographic impact of Lukas M. Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas M. Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas M. Braun more than expected).

Fields of papers citing papers by Lukas M. Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas M. Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas M. Braun. The network helps show where Lukas M. Braun may publish in the future.

Co-authorship network of co-authors of Lukas M. Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas M. Braun. A scholar is included among the top collaborators of Lukas M. Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas M. Braun. Lukas M. Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Braun, Lukas M., Yunjie Lu, & Robert Zeiser. (2025). Clinical perspective and treatment of immune-related colitis after cancer immunotherapy. Trends in cancer. 11(11). 1058–1077. 1 indexed citations

2.

Palmer, Brian D., Petr Tomek, Jack U. Flanagan, et al.. (2022). Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2. Pharmaceuticals. 15(9). 1090–1090. 3 indexed citations

3.

Oßwald, Lena, Shaima’a Hamarsheh, Franziska Maria Uhl, et al.. (2021). Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice. Molecular Cancer Research. 19(9). 1596–1608. 8 indexed citations

4.

Braun, Lukas M. & Robert Zeiser. (2021). Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease. Frontiers in Immunology. 12. 760199–760199. 29 indexed citations

5.

Hussung, Saskia, Lukas M. Braun, R. Klar, et al.. (2021). Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Scientific Reports. 11(1). 7499–7499. 11 indexed citations

6.

Braun, Lukas M. & Robert Zeiser. (2021). Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease. HemaSphere. 5(6). e581–e581. 16 indexed citations

7.

Uhl, Franziska Maria, Geoffroy Andrieux, Michele Proietti, et al.. (2020). Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect. Haematologica. 106(8). 2131–2146. 40 indexed citations

8.

Braun, Lukas M., et al.. (2020). Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Cells. 9(5). 1251–1251. 16 indexed citations

9.

Braun, Lukas M., Simon Lagies, R. Klar, et al.. (2020). Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures. Cancers. 12(6). 1440–1440. 18 indexed citations

10.

Braun, Lukas M. & Robert Zeiser. (2020). Immunotherapy in Myeloproliferative Diseases. Cells. 9(6). 1559–1559. 19 indexed citations

11.

Lagies, Simon, Manuel Schlimpert, Lukas M. Braun, et al.. (2019). Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry. Analytical and Bioanalytical Chemistry. 411(24). 6319–6328. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact